Lime already holds a permit with Portland Bureau of Transportation for e-scooters and they’ve worked closely with PBOT on the ...

Another surprise deal we spotted earlier was the 50% discount dropping the EVOLV TERRA full-suspension electric scooter to a ...

Sunrisers Hyderabad (SRH) are coming into IPL 2026 with a fresh look and their usual aggressive “attack-first” style. After a mixed performance in 2025, the team is focusing more on its strong batting ...

Royal Challengers Bengaluru head into IPL 2026 with a big responsibility on their shoulders they are now the defending champions. After finally winning their first ever IPL title last season under ...

Sold through the Nexa retail network, one of the key factors behind the Maruti Suzuki Baleno's popularity is its design. Maruti Suzuki offers a wide range of genuine accessories that can enhance its ...

MOTOR experts have revealed their pick of 20 best electric cars on sale right now. The list includes everything from budget-friendly runarounds to luxury motors with prices starting as little as £165 ...

As fuel prices jump, farming is one industry that's feeling the pinch more than most. Pennsylvania farmers say economic factors like diesel fuel and fertilizer costs are pushing them to the edge. On ...

Pennsylvania is among the top 10 states for the highest gas prices in the nation. According to AAA, as of March 9, Pennsylvania has an average price of $3.589 for regular gasoline, which is the eighth ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. A number of major drugmakers have reportedly raised the prices of hundreds of brand-name drugs, including some of the ...

Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50% beginning in 2027, the company announced on Tuesday. Wegovy currently carries a list price of $1,349 per ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.